Melanoma Clinical Trials

Showing 681-700 of 1,292 trials

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the investigational drug PLX2853 in subjects with advanced malignancies.

Small Cell Lung CancerUveal MelanomaOvarian Clear Cell Carcinoma+5 more

Opna Bio LLC49 participantsStarted Sep 2017

Scottsdale, Arizona, United States • Miami, Florida, United States • New York, New York, United States +2 more locations

UNKNOWNPhase 4

Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG

NCT05467137

In this study the investigators try to identify the sentinel lymph node in patients with stage Ib-III melanoma in a non-invasive manner without the use of a radioactive tracer by using the new MSOT technology.

Melanoma, Stage IMelanoma, Stage IIMelanoma Stage III

University Medical Center Groningen10 participantsStarted Sep 2022

COMPLETEDPhase 1/2

Study of PI-88 in Patients With Advanced Melanoma

NCT00068172

The purpose of this study is to determine whether PI-88 is safe and effective in the treatment of advanced melanoma.

Melanoma

Cellxpert Biotechnology Corp.88 participantsStarted Jul 2001

Aurora, Colorado, United States

COMPLETEDPhase 3

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

NCT02714218

The purpose of this study is to evaluate two different dose combinations of nivolumab and ipilimumab in the treatment of melanoma.

Melanoma

Bristol-Myers Squibb387 participantsStarted Apr 2016

Aurora, Colorado, United States • Tampa, Florida, United States • Fridley, Minnesota, United States +54 more locations

A Study of PLX2853 in Advanced Malignancies.

Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG

Study of PI-88 in Patients With Advanced Melanoma

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Related Searches

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)

Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer

Circulating Tumor Material in Colorectal Cancer and Melanoma

Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms

E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients

A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers